BE
Brian Elsbernd
Chief Legal Officer

Brian Elsbernd insider trades: Catalyst Pharmaceuticals (CPRX) stock sales

Chief Legal Officer, Catalyst Pharmaceuticals Last trade Nov 12, 2025 27 Form 4 filings
$908K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brian reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 12, 2025CPRX↓ Sell$908K
Sep 8, 2025CPRX↓ Sell$609K
Sep 4, 2025CPRX↓ Sell$987K
Mar 3, 2025CPRX↓ Sell$1.4M
Nov 26, 2024CPRX↓ Sell$287K
Mar 27, 2024CPRX↓ Sell$411K
Mar 20, 2023CPRX↓ Sell$803K
Nov 11, 2022CPRX↓ Sell$238K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CPRX insiders

Open-market trades in the last 12 months

About Brian Elsbernd's insider trades

Brian Elsbernd is Chief Legal Officer at Catalyst Pharmaceuticals (CPRX). Since Nov 11, 2022, Brian has reported no open-market purchases and 8 sales worth $5.7M on SEC Form 4. In the last 12 months: 1 sale ($908K).

Their filings also include option exercises (17 filings), shares withheld for taxes (9 filings), grants and awards (9 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CPRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.